Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycobiology of rheumatic diseases. | Nat Rev Rheumatol | 2023 | 36418483 | PubTator, text mining | PubMed |
| Genome-wide admixture and association analysis identifies African ancestry-specific risk loci of eosinophilic esophagitis in African Americans. | J Allergy Clin Immunol | 2023 | 36400179 | PubTator, text mining | PubMed |
| Recombinant mucin biotechnology and engineering. | Adv Drug Deliv Rev | 2023 | 36375719 | PubTator, text mining | PubMed |
| Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. | Noncoding RNA Res | 2023 | 36311994 | PubTator, text mining | PubMed |
| Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. | Mol Diagn Ther | 2023 | 36287372 | PubTator, text mining | PubMed |
| The disulfide catalyst QSOX1 maintains the colon mucosal barrier by regulating Golgi glycosyltransferases. | EMBO J | 2023 | 36245281 | PubTator, text mining | PubMed |
| Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma. | J Invest Dermatol | 2023 | 36174713 | PubTator, text mining | PubMed |
| α2,6-Sialylation promotes hepatocellular carcinoma cells migration and invasion via enhancement of nSmase2-mediated exosomal miRNA sorting. | J Physiol Biochem | 2023 | 35984620 | PubTator, text mining | PubMed |
| In silico screening-based discovery of inhibitors against glycosylation proteins dysregulated in cancer. | J Biomol Struct Dyn | 2023 | 34989310 | PubTator, text mining | PubMed |
| Applications and continued evolution of glycan imaging mass spectrometry. | Mass Spectrom Rev | 2023 | 34392557 | PubTator, text mining | PubMed |
| Systematic characterization of extracellular glycoproteins using mass spectrometry. | Mass Spectrom Rev | 2023 | 34047389 | PubTator, text mining | PubMed |
| Unique attributes of obesity in India: A narrative review. | Obes Med | 2022 | 38572212 | PubTator, text mining | PubMed |
| IgA Nephropathy: A Chinese Perspective. | Glomerular Dis | 2022 | 36751266 | PubTator, text mining | PubMed |
| Store-Operated Calcium Entry in Breast Cancer Cells Is Insensitive to Orai1 and STIM1 N-Linked Glycosylation. | Cancers (Basel) | 2022 | 36612199 | PubTator, text mining | PubMed |
| GARP dysfunction results in COPI displacement, depletion of Golgi v-SNAREs and calcium homeostasis proteins. | Front Cell Dev Biol | 2022 | 36578782 | PubTator, text mining | PubMed |
| The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions. | Int J Mol Sci | 2022 | 36555445 | PubTator, text mining | PubMed |
| Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy. | Int J Mol Sci | 2022 | 36555198 | PubTator, text mining | PubMed |
| Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer. | Biomedicines | 2022 | 36552021 | PubTator, text mining | PubMed |
| Switching azide and alkyne tags on bioorthogonal reporters in metabolic labeling of sialylatedglycoconjugates: a comparative study. | Sci Rep | 2022 | 36550357 | PubTator, text mining | PubMed |
| Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment. | Diseases | 2022 | 36547200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=16